Long-term thinking and emotional health after stem cell transplant for immune disorders
Part of Blood & lymphatic, Brain & nervous system, Immune system & allergy, Mental health clinical trials.
This study checks how children who had a stem cell transplant for a primary immune deficiency are doing emotionally and mentally, at least 2 years after the transplant. It helps us understand the long-term effects of this treatment on children's health and development.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child had a stem cell transplant at Necker Hospital in Paris.
- The transplant was for a primary immunodeficiency (a genetic disorder of the immune system).
- At least 2 years have passed since the transplant.
- Your child is currently between 6 and 8 years old (up to 8 years 11 months).
- Your child can speak French well enough for testing and has no major uncorrected hearing or vision problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the emotional and psychological impact on people who donate stem cells to a family member (a haploidentical donor). It aims to understand how the donation experience affects donors.
This study looks at how a stem cell transplant affects thinking and memory in children, and how the child's environment and physical abilities might help. Your family's participation could help find ways to support children's brain health after transplant.
This study looks at how a stem cell transplant affects memory, thinking, metabolism, and physical fitness in children and young adults. It aims to find ways to support brain health and overall well-being after treatment.
This study collects medical information from people with certain non-cancer conditions who receive a stem cell transplant. It may help doctors better understand transplant outcomes and care, since the study focuses on data collection rather than adding new treatment.
This study checks how people do long-term after stem cell transplant, cellular therapy, or gene therapy. It may help doctors track longer-term health effects and recovery and improve future care.
This study looks at immune cells in your blood and in tissues affected by chronic graft-versus-host disease (a condition where donor cells attack your body) after a stem cell transplant. By analyzing samples, researchers hope to better understand this condition and improve future treatments.
Hear when a new Allogeneic Hematopoietic Stem Cell Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.